U
UTHR
UTHRReviewed7 segments tracked|6 years of data|Annual (10-K)
Total Revenue
$2.9B24.1%
FY2024
Operating Segments
7Active segments
Blended Margin
0.0%Operating margin
Highest Margin
0.0%Tyvaso DPI
Segment Shift
Tyvaso DPI has grown from 0.0% to 36.2% of total revenue since FY2019, with 0.0% operating margins. Meanwhile, Product And Service Other is the fastest growing at +87.3% YoY.
Segment Revenue Over Time
Revenue Mix
Segment Breakdown — FY2024
| Segment | Revenue | Op. Income | Margin | % of Total | YoY |
|---|---|---|---|---|---|
| Tyvaso DPI | $1.0B | $0 | 0.0% | 36.2% | +41.4% |
| Nebulized Tyvaso | $587M | $0 | 0.0% | 20.6% | +16.8% |
| Remodulin | $538M | $0 | 0.0% | 18.9% | +8.8% |
| Orenitram | $434M | $0 | 0.0% | 15.2% | +20.8% |
| Unituxin | $239M | $0 | 0.0% | 8.4% | +20.0% |
| Product And Service Other | $22M | $0 | 0.0% | 0.8% | +87.3% |
| Adcirca | $1M | $0 | 0.0% | 0.0% | +0.0% |
Want more? Unlock the full analysis.
Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.
Get Started Free